Diagens-B 02526 IPO Allotment Results Analysis

Back Prospectus Allotment Results Allotment Profile Expected Lots Subscription Calculator Cibo Flash Quote ›

Data layers Raw facts Calculated Model prediction AI interpretation

Allotment Overview Calculated

Total Subscription Fees vs Public Offering Raise Amount

Subscription Tier Analysis Model prediction

Expected Lots Allotted by Subscription Tier

Pool A applications , Pool B applications . Expected lots allotted = "Approximate percentage of total shares applied for" as stated in the allotment announcement × shares applied ÷ lot size, taken directly from the announcement.

Capital Efficiency by Subscription Tier

Capital efficiency = Expected shares allotted ÷ shares applied × 100, i.e. the original "Approximate percentage of total shares applied for" value from the allotment announcement. The fewer shares applied for, the higher the capital efficiency.

Applicant Distribution by Subscription Tier

The vertical axis uses a logarithmic scale to better observe distribution differences across tiers of varying magnitudes. All four charts share the same x-axis; hover tooltips are synchronized.

Subscription Fee ÷ Allotted Market Value by Tier

Allotted market value = valid applicants × shares applied × (percentage applied for ÷ 100) × offer price; total handling fees = valid applicants × HKD 100; ratio = total fees ÷ allotted market value × 100%. Lower tiers have disproportionately high ratios due to very small allotments; ratios stabilize at higher tiers.

Allotment Results Subscription Tier List

International Offering Raw facts

3.45

International oversubscription

120

Placee count

Cornerstone investors

120

Anchor investors

AI AI Analysis AI interpretation deepseek-v4-pro · AI-generated

Market Sentiment

The IPO for Deshi-B (02526) saw an extraordinary oversubscription ratio of 1,073.37x, driven by intense retail enthusiasm for the 18A biotech listing. With a near-zero hit rate and 115,017 valid applications, the offer was heavily oversubscribed, indicating investors were willing to compete fiercely for shares at the HK$99 offer price. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Tier Analysis

Given the 1,073x oversubscription, expected allocation lots for the last A-tier (甲尾) and first B-tier (乙头) were likely to be extremely close, potentially eliminating the typical tier advantage. The extreme scale of oversubscription often renders broker fee efficiency negligible, as even top-tier applicants secured only minimal allocations. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Demographics

Demographic data for this IPO is unavailable; however, 18A biotech listings often attract strong mainland China interest, with Guangdong-based investors typically representing a significant share. Without concrete holder counts, regional and gender trends cannot be assessed. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

About this page

This page shows allotment analysis for Diagens-B (02526): one-lot hit rate, Pool A/B allotment distribution, oversubscription multiple, and grey-market and first-day performance. Data is parsed from the HKEX allotment results announcement. How allotment rates and clawback work is explained in How Hong Kong IPO Allotment Rates Work.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect

Diagens-B 02526·IPOIPO Allotment Results Analysis